Symbols / AMIX Stock $0.40 +0.62% Autonomix Medical, Inc.

Healthcare • Medical Devices • United States • NCM
AMIX (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Devices
CEO Mr. Bradley Hauser
Exch · Country NCM · United States
Market Cap 4.62M
Enterprise Value -2.39M
Income -16.71M
Sales —
FCF (ttm) -6.49M
Book/sh 0.52
Cash/sh 0.61
Employees —
Insider 10d —
IPO Jan 29, 2024
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E -0.05
PEG —
P/S —
P/B 0.78
P/C —
EV/EBITDA 0.14
EV/Sales —
Quick Ratio 4.11
Current Ratio 4.45
Debt/Eq —
LT Debt/Eq —
EPS (ttm) -2.32
EPS next Y -7.40
EPS Growth —
Revenue Growth —
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-02-11
Earnings (prior) 2026-02-11
ROA -122.33%
ROE -238.89%
ROIC —
Gross Margin 0.00%
Oper. Margin 0.00%
Profit Margin 0.00%
Shs Outstand 11.41M
Shs Float 11.06M
Insider Own 4.06%
Instit Own 4.15%
Short Float 5.73%
Short Ratio 0.36
Short Interest 646.07K
52W High 2.64
vs 52W High -84.67%
52W Low 0.20
vs 52W Low 102.35%
Beta -1.41
Impl. Vol. —
Rel Volume 0.12
Avg Volume 714.10K
Volume 84.93K
Target (mean) $2.80
Tgt Median $2.80
Tgt Low $2.00
Tgt High $3.60
# Analysts 2
Recom Strong_buy
Prev Close $0.40
Price $0.40
Change 0.62%
About

Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. The company's technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. It develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related disorders. Autonomix Medical, Inc. was incorporated in 2014 and is headquartered in The Woodlands, Texas.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$2.80
Mean price target
2. Current target
$0.40
Latest analyst target
3. DCF / Fair value
$-10.24
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.40
Low
$2.00
High
$3.60
Mean
$2.80

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-02-17 main Maxim Group Buy → Buy $2
2025-04-29 init Maxim Group — → Buy $5
2024-09-03 init Ladenburg Thalmann — → Buy $1
News
RSS: Latest AMIX news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2026-03-31 2025-03-31 2024-03-31 2023-03-31
Total Revenue
0.00
0.00
0.00
0.00
Operating Revenue
0.00
0.00
0.00
0.00
Operating Expense
17.03
+47.00%
11.59
+55.04%
7.47
+275.58%
1.99
Research And Development
7.14
+51.20%
4.72
+112.36%
2.23
+198.66%
0.74
Selling General And Administration
9.89
+44.11%
6.86
+30.75%
5.25
+321.61%
1.25
General And Administrative Expense
9.89
+44.11%
6.86
+30.75%
5.25
+321.61%
1.25
Other Gand A
9.89
+44.11%
6.86
+30.75%
5.25
+321.61%
1.25
Total Expenses
17.03
+47.00%
11.59
+55.04%
7.47
+275.58%
1.99
Operating Income
-17.03
-47.00%
-11.59
-55.04%
-7.47
-275.58%
-1.99
Total Operating Income As Reported
-17.03
-47.00%
-11.59
+3.67%
-12.03
-504.52%
-1.99
EBITDA
-16.70
-51.14%
-11.05
+27.61%
-15.27
-667.14%
-1.99
Normalized EBITDA
-16.70
-51.14%
-11.05
-52.09%
-7.27
-265.13%
-1.99
Reconciled Depreciation
0.01
-93.44%
0.18
+125.93%
0.08
0.00
EBIT
-16.71
-48.79%
-11.23
+26.80%
-15.35
-671.21%
-1.99
Total Unusual Items
—
—
-8.00
—
Total Unusual Items Excluding Goodwill
—
—
-8.00
—
Net Income
-16.71
-46.49%
-11.41
+26.03%
-15.43
-675.18%
-1.99
Pretax Income
-16.71
-46.49%
-11.41
+26.03%
-15.43
-675.18%
-1.99
Net Non Operating Interest Income Expense
0.32
+79.21%
0.18
+270.83%
0.05
0.00
Interest Expense Non Operating
0.00
-100.00%
0.18
+122.78%
0.08
0.00
Net Interest Income
0.32
+79.21%
0.18
+270.83%
0.05
0.00
Interest Expense
0.00
-100.00%
0.18
+122.78%
0.08
0.00
Interest Income Non Operating
0.32
-9.89%
0.35
+178.74%
0.13
0.00
Interest Income
0.32
-9.89%
0.35
+178.74%
0.13
0.00
Other Income Expense
—
—
-8.00
—
Gain On Sale Of Security
—
—
-8.00
—
Tax Provision
0.00
0.00
0.00
0.00
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-16.71
-46.49%
-11.41
+26.03%
-15.43
-675.18%
-1.99
Net Income From Continuing Operation Net Minority Interest
-16.71
-46.49%
-11.41
+26.03%
-15.43
-675.18%
-1.99
Net Income From Continuing And Discontinued Operation
-16.71
-46.49%
-11.41
+26.03%
-15.43
-675.18%
-1.99
Net Income Continuous Operations
-16.71
-46.49%
-11.41
+26.03%
-15.43
-675.18%
-1.99
Normalized Income
-16.71
-46.49%
-11.41
-53.65%
-7.43
-273.17%
-1.99
Net Income Common Stockholders
-16.71
-46.49%
-11.41
+26.03%
-15.43
-675.18%
-1.99
Diluted EPS
—
-6.46
+56.41%
-14.82
-686.35%
-1.88
Basic EPS
—
-6.46
+56.41%
-14.82
-686.35%
-1.88
Basic Average Shares
—
1.77
+69.73%
1.04
-1.44%
1.06
Diluted Average Shares
—
1.77
+69.73%
1.04
-1.44%
1.06
Diluted NI Availto Com Stockholders
-16.71
-46.49%
-11.41
+26.03%
-15.43
-675.18%
-1.99
Line Item Trend 2026-03-31 2025-03-31 2024-03-31 2023-03-31
Total Assets
7.60
-22.50%
9.81
+4.24%
9.41
+987.51%
0.86
Current Assets
7.58
-21.11%
9.61
+2.32%
9.39
+985.66%
0.86
Cash Cash Equivalents And Short Term Investments
7.00
-23.34%
9.14
+6.13%
8.61
+895.14%
0.86
Cash And Cash Equivalents
7.00
-23.34%
9.14
+6.13%
8.61
+895.14%
0.86
Cash Financial
—
—
8.61
+895.14%
0.86
Other Current Assets
0.58
+21.99%
0.47
-39.59%
0.78
—
Total Non Current Assets
0.02
-90.36%
0.20
+1131.25%
0.02
0.00
Net PPE
0.02
-9.52%
0.02
+31.25%
0.02
0.00
Non Current Deferred Assets
0.00
-100.00%
0.18
0.00
—
Total Liabilities Net Minority Interest
1.71
-0.12%
1.71
-4.05%
1.78
+704.98%
0.22
Current Liabilities
1.71
-0.12%
1.71
+119.69%
0.78
+251.58%
0.22
Payables And Accrued Expenses
1.11
+2.87%
1.08
+39.12%
0.78
+251.58%
0.22
Payables
0.75
+3.31%
0.73
+47.56%
0.49
+184.39%
0.17
Accounts Payable
0.70
+3.55%
0.68
+37.40%
0.49
+184.39%
0.17
Current Accrued Expenses
0.36
+1.97%
0.35
+24.56%
0.28
+493.75%
0.05
Pensionand Other Post Retirement Benefit Plans Current
0.59
-5.27%
0.63
—
—
Total Tax Payable
0.05
+0.00%
0.05
—
—
Total Non Current Liabilities Net Minority Interest
0.00
0.00
-100.00%
1.00
0.00
Long Term Debt And Capital Lease Obligation
—
—
1.00
—
Long Term Debt
—
—
1.00
—
Stockholders Equity
5.89
-27.21%
8.10
+6.17%
7.63
+1084.47%
0.64
Common Stock Equity
5.89
-27.21%
8.10
+6.17%
7.63
+1084.47%
0.64
Capital Stock
0.01
+450.00%
0.00
+100.00%
0.00
-91.67%
0.01
Common Stock
0.01
+450.00%
0.00
+100.00%
0.00
-91.67%
0.01
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
11.41
+356.92%
2.50
+164.99%
0.94
-10.76%
1.06
Ordinary Shares Number
11.41
+356.92%
2.50
+164.99%
0.94
-10.76%
1.06
Additional Paid In Capital
72.98
+24.80%
58.48
+25.50%
46.60
+92.74%
24.18
Retained Earnings
-67.09
-33.18%
-50.38
-29.28%
-38.97
-65.52%
-23.54
Total Equity Gross Minority Interest
5.89
-27.21%
8.10
+6.17%
7.63
+1084.47%
0.64
Total Capitalization
5.89
-27.21%
8.10
-6.15%
8.63
+1240.06%
0.64
Working Capital
5.88
-25.64%
7.90
-8.27%
8.61
+1237.58%
0.64
Invested Capital
5.89
-27.21%
8.10
-6.15%
8.63
+1240.06%
0.64
Total Debt
—
—
1.00
—
Net Tangible Assets
5.89
-27.21%
8.10
+6.17%
7.63
+1084.47%
0.64
Tangible Book Value
5.89
-27.21%
8.10
+6.17%
7.63
+1084.47%
0.64
Line Item Trend 2026-03-31 2025-03-31 2024-03-31 2023-03-31
Operating Cash Flow
-12.28
-48.73%
-8.26
-24.22%
-6.65
-258.58%
-1.85
Cash Flow From Continuing Operating Activities
-12.28
-48.73%
-8.26
-24.22%
-6.65
-258.58%
-1.85
Net Income From Continuing Operations
-16.71
-46.49%
-11.41
+26.03%
-15.43
-675.18%
-1.99
Depreciation Amortization Depletion
0.01
-93.44%
0.18
+125.93%
0.08
0.00
Depreciation And Amortization
0.01
-93.44%
0.18
+125.93%
0.08
0.00
Other Non Cash Items
3.73
+3595.05%
0.10
—
—
Stock Based Compensation
0.80
-51.11%
1.63
+163.43%
0.62
0.00
Operating Gains Losses
—
—
8.00
—
Gain Loss On Investment Securities
—
—
8.00
—
Change In Working Capital
-0.11
-108.63%
1.24
+1469.62%
0.08
-41.91%
0.14
Change In Payables And Accrued Expense
-0.00
-100.32%
0.93
+66.97%
0.56
+338.58%
0.13
Change In Accrued Expense
-0.03
-103.62%
0.75
+214.77%
0.24
+415.22%
0.05
Change In Payable
0.02
-86.96%
0.18
-42.50%
0.32
+295.06%
0.08
Change In Account Payable
0.02
-86.96%
0.18
-42.50%
0.32
+295.06%
0.08
Change In Other Current Assets
-0.10
-133.55%
0.31
+164.85%
-0.48
-5411.11%
0.01
Investing Cash Flow
-0.01
+28.57%
-0.01
+26.32%
-0.02
0.00
Cash Flow From Continuing Investing Activities
-0.01
+28.57%
-0.01
+26.32%
-0.02
0.00
Net PPE Purchase And Sale
-0.01
+28.57%
-0.01
+26.32%
-0.02
0.00
Purchase Of PPE
-0.01
+28.57%
-0.01
+26.32%
-0.02
0.00
Capital Expenditure
-0.01
+28.57%
-0.01
+26.32%
-0.02
—
Financing Cash Flow
10.16
+15.45%
8.80
-38.93%
14.41
+2034.81%
0.68
Cash Flow From Continuing Financing Activities
10.16
+15.45%
8.80
-38.93%
14.41
+2034.81%
0.68
Net Issuance Payments Of Debt
—
0.00
-100.00%
2.00
0.00
Issuance Of Debt
—
0.00
-100.00%
2.00
0.00
Long Term Debt Issuance
—
0.00
-100.00%
2.00
0.00
Net Long Term Debt Issuance
—
0.00
-100.00%
2.00
0.00
Net Common Stock Issuance
3.53
-64.79%
10.03
-26.84%
13.71
+1930.52%
0.68
Proceeds From Stock Option Exercised
2.55
+254500.00%
0.00
0.00
—
Net Other Financing Charges
4.08
+432.49%
-1.23
+5.25%
-1.30
—
Changes In Cash
-2.13
-503.79%
0.53
-93.18%
7.74
+756.74%
-1.18
Beginning Cash Position
9.14
+6.13%
8.61
+895.14%
0.86
-57.68%
2.04
End Cash Position
7.00
-23.34%
9.14
+6.13%
8.61
+895.14%
0.86
Free Cash Flow
-12.29
-48.60%
-8.27
-24.07%
-6.67
-259.60%
-1.85
Common Stock Issuance
3.53
-64.79%
10.03
-26.84%
13.71
+1930.52%
0.68
Issuance Of Capital Stock
3.53
-64.79%
10.03
-26.84%
13.71
+1930.52%
0.68
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category